Estrigenix Therapeutics, Inc. funding
Estrigenix Therapeutics, Inc., a pharmaceuticals company based in Wauwatosa, WI, filed a Form D with the SEC on July 27, 2026 and reported $1M raised of a $2M offering.
Amount raised$1M
Offering size$2M
Filed with the SECJuly 27, 2026
First saleJuly 17, 2026
IndustryPharmaceuticals
SecuritiesEquity
LocationWauwatosa, WI
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment$150K
Revenue rangeNo Revenues
View the original Form D on SEC EDGAR ↗ · All rounds filed Jul 27